Physician profile
Carson H Ling
NPI 1205929635
$1,395.04
in general payments reported to CMS, 2019-2025
22 companies · $76.74 in 2025
The $76.74 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $374 · 2021: $465 · 2022: $198 · 2024: $100 · 2025: $76.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $401.31 | 2019-2025 | General - Pain Management |
| Merz North America, INC. | $132.09 | 2022 | |
| Pfizer INC. | $107.52 | 2019-2021 | |
| Forte Bio-Pharma LLC | $96.09 | 2021-2022 | |
| Medtronic USA, INC. | $82.76 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.28 | 2021 | |
| Medtronic, INC. | $68.66 | 2021 | |
| Janssen Pharmaceuticals, INC | $61.85 | 2020 | |
| Nestle Healthcare Nutrition INC. | $46.99 | 2021 | |
| Abbvie INC. | $42.96 | 2021 | |
| Astellas Pharma US INC | $39.67 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.16 | 2019 | |
| Nalu Medical, INC. | $33.79 | 2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $28.75 | 2019-2020 | |
| Vertiflex, INC. | $24.46 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $20.63 | 2020 | |
| Daiichi Sankyo INC. | $19.27 | 2019 | |
| Fidia Pharma USA INC. | $18.75 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $16.25 | 2020 | |
| Shionogi INC | $13.74 | 2019 | |
| Allergan, INC. | $12.08 | 2020 | |
| Biodelivery Sciences International, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carson Ling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.